Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Intervention1: Vitamin D supplementation in women with Polycystic Ovarian syndrome: Supplementation with Vitamin D with calcium with Vitamin B complex and will be asked to review in OPD after 2weeks a
Sponsors
Rohilkhand Medical College and Hospital, Bareilly
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of PCOS is based on ESHRE guidelines, any 2 of the below if present Irregular menstrual cycles Clinical/ biochemical hyperandrogenism Polycystic ovarian morphology (PCOM)
Exclusion criteria
Exclusion criteria: Disorders showing similar clinical features like Cushing Syndrome, congential adrenal hyperplasia or androgen secreting tumors should be excluded to reach the diagnosis of Polycystic ovarian syndome. Hormonal contraception within 3 months and use of insulin sensitizing drugs (such as metformin, thiazolidinediones)within 6 months prior to study Use of lipid lowering drugs Known case of diabetes, Hypertension, thyroid disease, nephrolithiaisis or conditions resulting in hypercalcemia Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the role of supplementation of Vitamin D on metabolic status of women with Polycystic ovarian syndromeTimepoint: To analyse the status of Vitamin D levels in PCOS patients To assess the favourable metabolic outcome after supplementation with vitamin D in women with PCOS | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the role of supplementation of Vitamin D on metabolic status of women with Polycystic ovarian syndromeTimepoint: To determine the favourable reproductive outcome after Vitamin D supplementation in women with PCOS | — |
Countries
India
Contacts
Public ContactDr Lata Agrawal
Rohilkhand Medical College and Hospital
Outcome results
None listed